Topographic expression of p21WAF1/SDI1/CIP1, bcl2, and p53 is altered at the early stage of colorectal carcinogenesis

Jeong Hee Cho, Im Hwan Roe, Chang Young Lim, Dong Kook Park, Woo Ho Kim, Yong Il Kim

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

We analyzed the expression of p21, bcl2, and p53 in normal and different pathologic mucosa of the human colorectum using immunohistochemistry and cold polymerase chain reaction-single strand conformation polymorphism. The topography of normal mucosa showed; bcl2 and p53 expression restricted to basal epithelial cells and p21 expressed only in superficial epithelial cells. This topographic expression was altered in hyperplastic polyps and adenomas. Hyperplastic polyps revealed absence of or weak bcl2 expression and strong p21 expression without topography. In adenomas, whereas bcl2 expression increased and extended to parabasal and superficial dysplastic epithelium, the increase of p21 expression was limited to surface dysplastic epithelium. p53 was weakly expressed throughout the full thickness of dysplastic epithelium. Bcl2 expression in adenomas was stronger than in carcinomas; p53 expression was converse and p21 expression was variable. In carcinomas, this topographic expression was largely abrogated but p53 mutation (36%) was more frequent than in adenomas (2%). In carcinomas, p21 and p53 expression correlated inversely, but there was no relationship with bcl2. These results suggest that there is precisely ordered topographic pattern of p21, bcl2, and wild p53 expression in normal colorectal cells, but this becomes disordered during the early stage of colorectal carcinogenesis.

Original languageEnglish (US)
Pages (from-to)667-674
Number of pages8
JournalJournal of Korean Medical Science
Volume15
Issue number6
StatePublished - Dec 2000
Externally publishedYes

Fingerprint

Adenoma
Carcinogenesis
Epithelium
Polyps
Carcinoma
Mucous Membrane
Epithelial Cells
Refrigeration
Immunohistochemistry
Polymerase Chain Reaction
Mutation

Keywords

  • bcl2
  • Colorectal Carcinogenesis
  • Immunohistochemistry
  • p21
  • p53
  • PCR-SSCP
  • Topographic Expression

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Topographic expression of p21WAF1/SDI1/CIP1, bcl2, and p53 is altered at the early stage of colorectal carcinogenesis. / Cho, Jeong Hee; Roe, Im Hwan; Lim, Chang Young; Park, Dong Kook; Kim, Woo Ho; Kim, Yong Il.

In: Journal of Korean Medical Science, Vol. 15, No. 6, 12.2000, p. 667-674.

Research output: Contribution to journalArticle

Cho, Jeong Hee ; Roe, Im Hwan ; Lim, Chang Young ; Park, Dong Kook ; Kim, Woo Ho ; Kim, Yong Il. / Topographic expression of p21WAF1/SDI1/CIP1, bcl2, and p53 is altered at the early stage of colorectal carcinogenesis. In: Journal of Korean Medical Science. 2000 ; Vol. 15, No. 6. pp. 667-674.
@article{363e588a95d344c2848a91468fa62d7c,
title = "Topographic expression of p21WAF1/SDI1/CIP1, bcl2, and p53 is altered at the early stage of colorectal carcinogenesis",
abstract = "We analyzed the expression of p21, bcl2, and p53 in normal and different pathologic mucosa of the human colorectum using immunohistochemistry and cold polymerase chain reaction-single strand conformation polymorphism. The topography of normal mucosa showed; bcl2 and p53 expression restricted to basal epithelial cells and p21 expressed only in superficial epithelial cells. This topographic expression was altered in hyperplastic polyps and adenomas. Hyperplastic polyps revealed absence of or weak bcl2 expression and strong p21 expression without topography. In adenomas, whereas bcl2 expression increased and extended to parabasal and superficial dysplastic epithelium, the increase of p21 expression was limited to surface dysplastic epithelium. p53 was weakly expressed throughout the full thickness of dysplastic epithelium. Bcl2 expression in adenomas was stronger than in carcinomas; p53 expression was converse and p21 expression was variable. In carcinomas, this topographic expression was largely abrogated but p53 mutation (36{\%}) was more frequent than in adenomas (2{\%}). In carcinomas, p21 and p53 expression correlated inversely, but there was no relationship with bcl2. These results suggest that there is precisely ordered topographic pattern of p21, bcl2, and wild p53 expression in normal colorectal cells, but this becomes disordered during the early stage of colorectal carcinogenesis.",
keywords = "bcl2, Colorectal Carcinogenesis, Immunohistochemistry, p21, p53, PCR-SSCP, Topographic Expression",
author = "Cho, {Jeong Hee} and Roe, {Im Hwan} and Lim, {Chang Young} and Park, {Dong Kook} and Kim, {Woo Ho} and Kim, {Yong Il}",
year = "2000",
month = "12",
language = "English (US)",
volume = "15",
pages = "667--674",
journal = "Journal of Korean Medical Science",
issn = "1011-8934",
publisher = "Korean Academy of Medical Science",
number = "6",

}

TY - JOUR

T1 - Topographic expression of p21WAF1/SDI1/CIP1, bcl2, and p53 is altered at the early stage of colorectal carcinogenesis

AU - Cho, Jeong Hee

AU - Roe, Im Hwan

AU - Lim, Chang Young

AU - Park, Dong Kook

AU - Kim, Woo Ho

AU - Kim, Yong Il

PY - 2000/12

Y1 - 2000/12

N2 - We analyzed the expression of p21, bcl2, and p53 in normal and different pathologic mucosa of the human colorectum using immunohistochemistry and cold polymerase chain reaction-single strand conformation polymorphism. The topography of normal mucosa showed; bcl2 and p53 expression restricted to basal epithelial cells and p21 expressed only in superficial epithelial cells. This topographic expression was altered in hyperplastic polyps and adenomas. Hyperplastic polyps revealed absence of or weak bcl2 expression and strong p21 expression without topography. In adenomas, whereas bcl2 expression increased and extended to parabasal and superficial dysplastic epithelium, the increase of p21 expression was limited to surface dysplastic epithelium. p53 was weakly expressed throughout the full thickness of dysplastic epithelium. Bcl2 expression in adenomas was stronger than in carcinomas; p53 expression was converse and p21 expression was variable. In carcinomas, this topographic expression was largely abrogated but p53 mutation (36%) was more frequent than in adenomas (2%). In carcinomas, p21 and p53 expression correlated inversely, but there was no relationship with bcl2. These results suggest that there is precisely ordered topographic pattern of p21, bcl2, and wild p53 expression in normal colorectal cells, but this becomes disordered during the early stage of colorectal carcinogenesis.

AB - We analyzed the expression of p21, bcl2, and p53 in normal and different pathologic mucosa of the human colorectum using immunohistochemistry and cold polymerase chain reaction-single strand conformation polymorphism. The topography of normal mucosa showed; bcl2 and p53 expression restricted to basal epithelial cells and p21 expressed only in superficial epithelial cells. This topographic expression was altered in hyperplastic polyps and adenomas. Hyperplastic polyps revealed absence of or weak bcl2 expression and strong p21 expression without topography. In adenomas, whereas bcl2 expression increased and extended to parabasal and superficial dysplastic epithelium, the increase of p21 expression was limited to surface dysplastic epithelium. p53 was weakly expressed throughout the full thickness of dysplastic epithelium. Bcl2 expression in adenomas was stronger than in carcinomas; p53 expression was converse and p21 expression was variable. In carcinomas, this topographic expression was largely abrogated but p53 mutation (36%) was more frequent than in adenomas (2%). In carcinomas, p21 and p53 expression correlated inversely, but there was no relationship with bcl2. These results suggest that there is precisely ordered topographic pattern of p21, bcl2, and wild p53 expression in normal colorectal cells, but this becomes disordered during the early stage of colorectal carcinogenesis.

KW - bcl2

KW - Colorectal Carcinogenesis

KW - Immunohistochemistry

KW - p21

KW - p53

KW - PCR-SSCP

KW - Topographic Expression

UR - http://www.scopus.com/inward/record.url?scp=0034577716&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034577716&partnerID=8YFLogxK

M3 - Article

C2 - 11194193

AN - SCOPUS:0034577716

VL - 15

SP - 667

EP - 674

JO - Journal of Korean Medical Science

JF - Journal of Korean Medical Science

SN - 1011-8934

IS - 6

ER -